Immobilization of enzymes, adsorbents, or both within semipermeable microcapsules (artificial cells) for clinical and experimental treatment of metabolite-related disorders.
D020642:Acatalasia; D000284:Administration, Oral; D000818:Animals; D001215:Asparaginase / Q000008:administration & dosage* / Q000494:pharmacology; D001216:Asparagine / Q000378:metabolism; D002374:Catalase / Q000008:administration & dosage* / Q000097:blood; D004195:Disease Models, Animal; D004798:Enzymes / Q000008:administration & dosage / Q000172:deficiency; D007274:Injections, Intraperitoneal; D007676:Kidney Failure, Chronic / Q000188:drug therapy; D007688:Kidneys, Artificial / Q000379:methods; D008228:Lymphoma, Non-Hodgkin / Q000378:metabolism; D008567:Membranes, Artificial; D008659:Metabolic Diseases / Q000188:drug therapy*; D051379:Mice; D009374:Neoplasms, Experimental / Q000378:metabolism; D010539:Permeability; D010592:Pharmaceutic Aids / Q000008:administration & dosage* / Q000138:chemical synthesis; D012513:Sarcoma, Experimental / Q000378:metabolism; D012995:Solubility; D014508:Urea / Q000378:metabolism; D014510:Urease / Q000008:administration & dosage* / Q000627:therapeutic use; D014511:Uremia / Q000188:drug therapy
D004798:Enzymes; D008567:Membranes, Artificial; D010592:Pharmaceutic Aids; D001216:Asparagine; D014508:Urea; D002374:Catalase; D001215:Asparaginase; D014510:Urease